Montis Biosciences

About:

Montis Biosciences is develops novel immune-oncology therapeutics targeting the intersection between vascular dysfunction.

Website: https://www.montisbio.com/

Top Investors: Polaris Partners, Pfizer Venture Investments, VIB, Agentschap Innoveren & Ondernemen, ALSA Ventures

Description:

Montis Biosciences is develops novel immune-oncology therapeutics targeting the intersection between vascular dysfunction and immune suppression to treat solid tumours.

Total Funding Amount:

9.4M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Meise, Vlaams-Brabant, Belgium

Founded Date:

2020-01-01

Contact Email:

info(AT)montisbio.com

Founders:

Luc Dochez, Massimiliano Mazzone, Peter Carmeliet

Number of Employees:

1-10

Last Funding Date:

2021-06-14

IPO Status:

Private

Industries: